In contrast to leptin, adiponectin generally has anti-tumorigenic effects, and its levels are often reduced in obesity, leading to an increased risk of gastrointestinal cancers through several mechanisms [41]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.